Kuwait - Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Human and Animal Blood in Kuwait - 2021
Contents:
- Price for Human and Animal Blood in Kuwait (CIF) - 2022
- Price for Human and Animal Blood in Kuwait (FOB) - 2022
- Imports of Human and Animal Blood in Kuwait
- Exports of Human and Animal Blood in Kuwait
Price for Human and Animal Blood in Kuwait (CIF) - 2022
In 2022, the average human and animal blood import price amounted to $256,354 per ton, dropping by -8.4% against the previous year. In general, the import price saw a pronounced downturn. The pace of growth appeared the most rapid in 2021 when the average import price increased by 24%. Over the period under review, average import prices reached the maximum at $339,192 per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Ireland ($1,117,854 per ton), while the price for New Zealand ($11,216 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+21.2%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Human and Animal Blood in Kuwait (FOB) - 2022
The average human and animal blood export price stood at $14,535 per ton in 2022, declining by -57.3% against the previous year. Overall, the export price recorded a perceptible decrease. The pace of growth appeared the most rapid in 2018 an increase of 222%. As a result, the export price attained the peak level of $126,620 per ton. From 2019 to 2022, the average export prices failed to regain momentum.
There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was Germany ($135,589 per ton), while the average price for exports to Cyprus ($1,259 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Qatar (+9.5%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Human and Animal Blood in Kuwait
In 2022, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported into Kuwait rose modestly to 104 tons, picking up by 2.9% against the previous year. The total import volume increased at an average annual rate of +7.6% over the period from 2019 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2020 with an increase of 33%. As a result, imports attained the peak of 111 tons. From 2021 to 2022, the growth of imports failed to regain momentum.
In value terms, human and animal blood imports declined to $27M in 2022. The total import value increased at an average annual rate of +10.2% from 2019 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2020 with an increase of 26%.
| Import of Human and Animal Blood in Kuwait (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Ireland | 6.3 | 5.2 | 6.7 | 7.5 | 6.0% |
| United States | 6.7 | 7.9 | 6.1 | 5.4 | -6.9% |
| Denmark | 2.1 | 4.4 | 4.1 | 5.3 | 36.2% |
| United Kingdom | 0.1 | 0.5 | 2.7 | 3.4 | 224.0% |
| Switzerland | N/A | N/A | 1.0 | 1.1 | 10.0% |
| Jordan | 0.9 | 0.5 | 0.7 | 0.8 | -3.9% |
| Germany | 2.4 | 3.2 | 5.9 | 0.8 | -30.7% |
| United Arab Emirates | N/A | 2.1 | N/A | 0.6 | -46.5% |
| France | 0.1 | 0.1 | 0.3 | 0.3 | 44.2% |
| Saudi Arabia | 0.5 | N/A | N/A | 0.2 | -26.3% |
| New Zealand | N/A | 0.1 | 0.1 | 0.1 | 0.0% |
| Others | 0.9 | 1.1 | 0.7 | 1.0 | 3.6% |
| Total | 19.9 | 25.1 | 28.3 | 26.7 | 10.3% |
Top Suppliers of Human and Animal Blood to Kuwait in 2022:
- Jordan (41.2 tons)
- New Zealand (10.1 tons)
- Denmark (9.9 tons)
- United Kingdom (6.9 tons)
- Ireland (6.8 tons)
- United States (6.5 tons)
- Saudi Arabia (4.6 tons)
- France (3.9 tons)
- United Arab Emirates (3.0 tons)
- Switzerland (2.9 tons)
- Germany (1.7 tons)
Exports of Human and Animal Blood in Kuwait
In 2022, approx. 5.9 tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported from Kuwait; rising by 128% on the previous year's figure. In general, exports showed a significant increase. The most prominent rate of growth was recorded in 2020 with an increase of 1,941%. The exports peaked in 2022 and are expected to retain growth in years to come.
In value terms, human and animal blood exports fell to $86K in 2022. Overall, exports posted a significant expansion. The pace of growth was the most pronounced in 2020 with an increase of 581% against the previous year.
| Export of Human and Animal Blood in Kuwait (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Qatar | 9.9 | 56.3 | 35.3 | 30.1 | 44.9% |
| United Kingdom | 0.4 | 18.0 | 6.9 | 28.9 | 316.5% |
| Germany | 0.1 | 1.0 | 11.3 | 13.8 | 416.8% |
| United Arab Emirates | 0.8 | 6.2 | 11.0 | 7.2 | 108.0% |
| France | 0.7 | 1.3 | 8.3 | 5.4 | 97.6% |
| Cyprus | N/A | N/A | 0.1 | 0.1 | 0.0% |
| Jordan | N/A | N/A | 14.6 | N/A | 0% |
| Others | 0.5 | 1.2 | 0.9 | 0.8 | 17.0% |
| Total | 12.3 | 84.0 | 88.5 | 86.3 | 91.4% |
Top Export Markets for Human and Animal Blood from Kuwait in 2022:
- United Kingdom (4759.0 kg)
- United Arab Emirates (501.0 kg)
- Qatar (333.0 kg)
- Cyprus (115.0 kg)
- Germany (102.0 kg)
- France (96.0 kg)
This report provides an in-depth analysis of the market for human and animal blood in Kuwait. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
- Kuwait
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Kuwait
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
374
This report provides an in-depth analysis of the market for human and animal blood in Kuwait.
359
This report provides an in-depth analysis of the antisera market in Kuwait.
375
This report provides an in-depth analysis of the vaccine market in Kuwait.
271
This report provides an in-depth analysis of the biological product market in Kuwait.
465
This report provides an in-depth analysis of the veterinary medicine vaccines market in Kuwait.
653
This report provides an in-depth analysis of the global market for human and animal blood.
2306
This report provides an in-depth analysis of the global antisera market.
2856
This report provides an in-depth analysis of the global vaccine market.
565
This report provides an in-depth analysis of the global biological product market.
760
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
291
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1181
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1084
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1274
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1275
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3246
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
510
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
606
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1233
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
245
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
